$AMGN
Amgen Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$403.99
▲+0.24%+$0.950
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAmgen Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is AMGN up today? It is at $403.99 (+0.24%), and our scanner flagged it 120 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AMGN spikes, and full due diligence on AMGN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AMGN 120 times in the last 30 days. Create a free account to track $AMGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AMGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AMGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAMGEN INC: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing3Initial insider ownership (Form 3)Sep 4, 2026 · 31 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
About $4.0B in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Khosla Rachna Officer | Sold (automatic/other) | -1K | sold 16% | 6K | $521K at $416.43 | Aug 13, 26 |
Khosla Rachna Officer | Other | 1K | added 20% | 8K | $204K at $162.60 | Aug 13, 26 |
Khosla Rachna Officer | Sold (automatic/other) | -2K | sold 24% | 6K | $825K at $412.57 | Aug 11, 26 |
Drake Michael V Director | Acquired (grant/award) | +64 | added 1.1% | 6K | n/a | Aug 7, 26 |
Holley Charles M Director | Acquired (grant/award) | +103 | added 0.8% | 13K | n/a | Aug 7, 26 |
Ishrak Omar Director | Acquired (grant/award) | +85 | added 1.1% | 7K | n/a | Aug 7, 26 |
Busch Matthew C. Officer | Acquired (grant/award) | +730 | added 17% | 5K | n/a | Aug 7, 26 |
Grygiel Nancy A. Officer | Sold (automatic/other) | -3K | sold 29% | 7K | $1.2M at $402.16 | Aug 6, 26 |
Grygiel Nancy A. Officer | Other | 3K | added 47% | 9K | $527K at $177.31 | Aug 6, 26 |
Miller Derek Officer | Sold (automatic/other) | -4K | sold 24% | 12K | $1.6M at $402.54 | Aug 6, 26 |
Miller Derek Officer | Other | 4K | added 37% | 15K | $633K at $162.60 | Aug 6, 26 |
Austin Wanda M Director | Acquired (grant/award) | +665 | added 9.0% | 8K | n/a | May 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Curated groups AMGN belongs to. Tap one to see every member with today's move and why the group is moving.
Here is the latest on AMGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AMGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AMGN last traded at $403.99, up 0.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Amgen Inc (AMGN) is next expected to report earnings on Tuesday, November 3, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. AMGN currently has a dividend yield of about 2.5% ($10.08 per share per year). Dividend figures can change; this is not investment advice.
The AMGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AMGN 120 times in the last 30 days.
AMGN (Amgen Inc) trades on XNAS, with a market cap of about $217.86B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AMGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AMGN discussion
Sign in to ask a question or join the discussion.